Cucurbitacin e has neuroprotective properties and autophagic modulating activities on dopaminergic neurons

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Arel Dubeau, Anne Marie ^a   Longpré, Fanny ^a   Bournival, Julie ^a   Tremblay, Cindy ^a   Demers Lamarche, Julie ^a   Haskova, Pavlina ^a,b   Attard, Everaldo ^c   Germain, Marc ^a   Martinoli, Maria Grazia ^a,d  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

^b Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^c UNIVERSITY OF MALTA   (Malta)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; DISEASE CONTROL; NEURODEGENERATIVE DISEASES; OXYGEN;

1-METHYL-4-PHENYLPYRIDINIUM; ANTIAPOPTOTIC PROPERTIES; DOPAMINERGIC NEURONS; N ,N-DIETHYLDITHIOCARBAMATE; NEURODEGENERATIVE DISORDERS; NEUROPROTECTIVE EFFECTS; PARKINSON'S DISEASE; REACTIVE OXYGEN SPECIES;

NEURONS;

1 METHYL 4 PHENYLPYRIDINIUM; CUCURBITACIN; CUCURBITACIN E; DIETHYLDITHIOCARBAMIC ACID; NEUROPROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; TRITERPENE;

APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL DAMAGE; CELL DEATH; CELL SURVIVAL; CELL VACUOLE; CONTROLLED STUDY; CYTOSKELETON; DNA DENATURATION; DOPAMINERGIC NERVE CELL; ECBALLIUM ELATERIUM; ENZYME INHIBITION; INTERMEDIATE FILAMENT; MITOSIS; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PC12 CELL LINE; WESTERN BLOTTING; ANIMAL; CYTOLOGY; DRUG EFFECTS; HUMAN; METABOLISM; PATHOLOGY; RAT;

CUCURBITACEAE; ECBALLIUM ELATERIUM; PARKINSONIA;

ANIMALS; APOPTOSIS; AUTOPHAGY; DOPAMINERGIC NEURONS; HUMANS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PARKINSON DISEASE; PC12 CELLS; RATS; REACTIVE OXYGEN SPECIES; TRITERPENES;

EID: 84919799054     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/425496     Document Type: Article

References (94)

1. D. A. Butterfield and J. Kanski, "Brain protein oxidation in agerelated neurodegenerative disorders that are associated with aggregated proteins," Mechanisms of Ageing and Development, vol. 122, no. 9, pp. 945-962, 2001.
2. A. H. V. Schapira and M. Gegg, "Mitochondrial contribution to parkinson's disease pathogenesis," Parkinson's Disease, vol. 2011, Article ID 159160, 7 pages, 2011.
3. S. Gandhi and A. Y. Abramov, "Mechanism of oxidative stress in neurodegeneration," OxidativeMedicine and Cellular Longevity, vol. 2012, Article ID428010, 11 pages, 2012.
4. W. Dauer and S. Przedborski, "Parkinson's disease: mechanisms and models," Neuron, vol. 39, no. 6, pp. 889-909, 2003.
5. P. M. Keeney, J. Xie, R. A. Capaldi, and J. P. Bennett Jr., "Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled," Journal of Neuroscience, vol. 26, no. 19, pp. 5256-5264, 2006.
6. A. H. Schapira and P. Jenner, "Etiology and pathogenesis of Parkinson's disease," Movement Disorders, vol. 26, no. 6, pp. 1049-1055, 2011.
7. J. Narkiewicz, G. Giachin, and G. Legname, "In vitro aggregation assays for the characterization of synuclein prion-like properties," Prion, vol. 8, no. 1, pp. 19-32, 2014.
8. D. C. Rubinsztein, M. DiFiglia, N. Heintz et al., "Autophagy and its possible roles in nervous system diseases, damage and repair.," Autophagy, vol. 1, no. 1, pp. 11-22, 2005.
9. B. Boland and R. A. Nixon, "Neuronal macroautophagy: from development to degeneration," Molecular Aspects of Medicine, vol. 27, no. 5-6, pp. 503-519, 2006.
10. D. Butler, R. A. Nixon, and B. A. Bahr, "Potential compensatory responses through autophagic/lysosomal pathways in neurodegenerative diseases," Autophagy, vol. 2, no. 3, pp. 234-237, 2006.
11. R. Banerjee,M. F. Beal, and B. Thomas, "Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications," Trends in Neurosciences, vol. 33, no. 12, pp. 541-549, 2010.
12. G. Twig, A. Elorza, A. J. A. Molina et al., "Fission and selective fusion govern mitochondrial segregation and elimination by autophagy," EMBO Journal, vol. 27, no. 2, pp. 433-446, 2008.
13. P. Muñoz, S. Huenchuguala, I. Paris, and J. Segura-Aguilar, "Dopamine oxidation and autophagy," Parkinson's Disease, vol. 2012, Article ID920953, 13 pages, 2012.
14. M. G. Spillantini, R. A. Crowther,R. Jakes,M. Hasegawa, and M. Goedert, "Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies," Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 11, pp. 6469-6473, 1998.
15. G. Krebiehl, S. Ruckerbauer, L. F. Burbulla et al., "Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1," PLoS ONE, vol. 5, no. 2, Article ID e9367, 2010.
16. L. Alvarez-Erviti, M. C. Rodriguez-Oroz, J. M. Cooper et al., "Chaperone-mediated autophagy markers in Parkinson disease brains," Archives of Neurology, vol. 67, no. 12, pp. 1464-1472, 2010.
17. D. Narendra, A. Tanaka, D.-F. Suen, and R. J. Youle, "Parkin is recruited selectively to impaired mitochondria and promotes their autophagy,"The Journal of Cell Biology, vol. 183, no. 5, pp. 795-803, 2008.
18. I. Irrcher, H. Aleyasin, E. L. Seifert et al., "Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics," Human Molecular Genetics, vol. 19, no. 19, pp. 3734-3746, 2010.
19. J.-Y. Lee, Y. Nagano, J. P. Taylor, K. L. Lim, and T.-P. Yao, "Disease-causing mutations in Parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy,"The Journal of Cell Biology, vol. 189, no. 4, pp. 671-679, 2010.
20. J. H. Son, J. H. Shim, K.-H. Kim, J.-Y. Ha, and J. Y. Han, "Neuronal autophagy and neurodegenerative diseases," Experimental and Molecular Medicine, vol. 44, no. 2, pp. 89-98, 2012.
21. J. Segura-Aguilar and R. M. Kostrzewa, "Neurotoxins and neurotoxic species implicated in neurodegeneration," Neurotoxicity Research, vol. 6, no. 7-8, pp. 615-630, 2004.
22. L. Zuo and M. S. Motherwell, "The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease," Gene, vol. 532, no. 1, pp. 18-23, 2013.
23. J. Blanchet, F. Longpré, G. Bureau et al., "Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice," Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 32, no. 5, pp. 1243-1250, 2008.
24. J. Blesa, S. Phani, V. Jackson-Lewis, and S. Przedborski, "Classic and new animal models of Parkinson's disease," Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 845618, 10 pages, 2012.
25. V. Annese, M.-T. Herrero, M. Di Pentima et al., "Metalloproteinase-9 contributes to inflammatory glia activation and nigro-striatal pathway degeneration in both mouse and monkey models of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism," Brain Structure and Function, 2014.
26. A. Schober, "Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP," Cell and Tissue Research, vol. 318, no. 1, pp. 215-224, 2004.
27. S. Przedborski, K. Tieu,C. Perier, and M. Vila, "MPTP as a mitochondrial neurotoxic model of Parkinson's disease," Journal of Bioenergetics and Biomembranes, vol. 36, no. 4, pp. 375-379, 2004.
28. S. Gélinas and M.-G. Martinoli, "Neuroprotective effect of estradiol and phytoestrogens on MPP+-induced cytotoxicity in neuronal PC12 cells," Journal of Neuroscience Research, vol. 70, no. 1, pp. 90-96, 2002.
29. K. B. Pandey and S. I. Rizvi, "Plant polyphenols as dietary antioxidants in human health and disease," Oxidative Medicine and Cellular Longevity, vol. 2, no. 5, pp. 270-278, 2009.
30. M. Iriti, S. Vitalini, G. Fico, and F. Faoro, "Neuroprotective herbs and foods fromdifferent traditional medicines and diets," Molecules, vol. 15, no. 5, pp. 3517-3555, 2010.
31. N. A. Kelsey,H. M. Wilkins, and D. A. Linseman, "Nutraceutical antioxidants as novel neuroprotective agents,"Molecules, vol. 15, no. 11, pp. 7792-7814, 2010.
32. H. C. Campos, M. D. D. Rocha, F. P. D. Viegas et al., "The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders I: Parkinson's disease," CNS and Neurological Disorders-Drug Targets, vol. 10, no. 2, pp. 239-250, 2011.
33. B. J. Small, K. S. Rawson, C. Martin et al., "Nutraceutical intervention improves older adults' cognitive functioning," Rejuvenation Research, vol. 17, no. 1, pp. 27-32, 2014.
34. S. E. Seidl, J. A. Santiago, H. Bilyk, and J. A. Potashkin, "The emerging role of nutrition in Parkinson's disease," Frontiers in Aging Neuroscience, vol. 6, article 36, pp. 1-13, 2014.
35. M. Stefani and S. Rigacci, "Beneficial properties of natural phenols: highlight on protection against pathological conditions associated with amyloid aggregation," BioFactors, vol. 40, no. 5, pp. 482-493, 2014.
36. T. Tannin-Spitz, M. Bergman, and S. Grossman, "Cucurbitacin glucosides: antioxidant and free-radical scavenging activities," Biochemical and Biophysical ResearchCommunications, vol. 364, no. 1, pp. 181-186, 2007.
37. J. Sun, M. A. Blaskovich, R. Jove, S. K. Livingston, D. Coppola, and S. M. Sebti, "Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity," Oncogene, vol. 24, no. 20, pp. 3236-3245, 2005.
38. S. I. Abdelwahab, L. E. A. Hassan, H. M. Sirat et al., "Antiinflammatory activities of cucurbitacin e isolated fromCitrullus lanatus var. citroides: role of reactive nitrogen species and cyclooxygenase enzyme inhibition," Fitoterapia, vol. 82, no. 8, pp. 1190-1197, 2011.
39. B. Jayaprakasam, N. P. Seeram, and M. G. Nair, "Anticancer and antiinflammatory activities of cucurbitacins from Cucurbita and reana," Cancer Letters, vol. 189, no. 1, pp. 11-16, 2003.
40. W.-W. Huang, J.-S. Yang, M.-W. Lin et al., "Cucurbitacin E induces G2/M phase arrest through STAT3/p53/p21 signaling and provokes apoptosis via Fas/CD95 and mitochondriadependent pathways in human bladder cancer T24 cells," Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID952762, 11 pages, 2012.
41. E. Attard and A. Cuschieri, "Cytotoxicity of Cucurbitacin E extracted from Ecballium elateriumin vitro," Journal of Natural Remedies, vol. 4, no. 2, pp. 137-144, 2004.
42. P. M. Sörensen, R. E. Iacob, M. Fritzsche et al., "The natural product cucurbitacin E inhibits depolymerization of actin filaments," ACS Chemical Biology, vol. 7, no. 9, pp. 1502-1508, 2012.
43. E. Attard, A. Cuschieri, and M. P. Brincat, "Morphological effects induced by Cucurbitacin E on ovarian cancer cells in vitro," Journal of Natural Remedies, vol. 5, no. 1, pp. 70-74, 2005.
44. K. L. K. Duncan, M. D. Duncan, M. C. Alley, and E. A. Sausville, "Cucurbitacin E-induced disruption of the actin and vimentin cytoskeleton in prostate carcinoma cells," Biochemical Pharmacology, vol. 52, no. 10, pp. 1553-1560, 1996.
45. K. Momma, Y. Masuzawa, N. Nakai et al., "Direct interaction of Cucurbitacin E isolated from Alsomitra macrocarpa to actin filament," Cytotechnology, vol. 56, no. 1, pp. 33-39, 2008.
46. E. Attard, "Rapid detection of cucurbitacins in tissues and in vitro cultures of Ecballiumelaterium(L.) A. Rich," CGC Reports, vol. 25, pp. 71-75, 2002.
47. J. Bournival, M.-A. Francoeur, J. Renaud, and M.-G. Martinoli, "Quercetin and sesamin protect neuronal PC12 cells fromhighglucose-induced oxidation, nitrosative stress, and apoptosis," Rejuvenation Research, vol. 15, no. 3, pp. 322-333, 2012.
48. J. Bournival, P. Quessy, and M. G. Martinoli, "Protective effects of resveratrol and quercetin againstMPP+-induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons," Cellular and Molecular Neurobiology, vol. 29, no. 8, pp. 1169-1180, 2009.
49. A. Yamamoto, Y. Tagawa, T. Yoshimori, Y. Moriyama, R. Masaki, and Y. Tashiro, "Bafilomycin A1 preventsmaturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells," Cell Structure and Function, vol. 23, no. 1, pp. 33-42, 1998.
50. I. G. Ganley, P.-M. Wong, N. Gammoh, and X. Jiang, "Disctinct autophagosomal-lysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest,"Molecular Cell, vol. 42, no. 6, pp. 731-743, 2011.
51. C. H. Jung, S.-H. Ro, J. Cao, N. M. Otto, and D.-H. Kim Do-Hyung, "mTOR regulation of autophagy," FEBS Letters, vol. 584, no. 7, pp. 1287-1295, 2010.
52. G. Haslam,D. Wyatt, and P. A. Kitos, "Estimating the number of viable animal cells in multi-well cultures based on their lactate dehydrogenase activities," Cytotechnology, vol. 32, no. 1, pp. 63-75, 2000.
53. J. Bournival, M. Plouffe, J. Renaud, C. Provencher, and M.-G. Martinoli, "Quercetin and sesamin protect dopaminergic cells from MPP+-induced neuroinflammation in a microglial (N9)-neuronal (PC12) coculture system," Oxidative Medicine and Cellular Longevity, vol. 2012,Article ID 921941, 11 pages, 2012.
54. O. S. Frankfurt and A. Krishan, "Identification of apoptotic cells by formamide-induced DNA denaturation in condensed chromatin," Journal of Histochemistry and Cytochemistry, vol. 49, no. 3, pp. 369-378, 2001.
55. J. Carange, F. Longpré, B. Daoust, and M. G. Martinoli, "24-epibrassinolide, a phytosterol from the brassinosteroid family, protects dopaminergic cells against MPP+-induced oxidative stress and apoptosis," Journal of Toxicology, vol. 2011, Article ID 392859, 13 pages, 2011.
56. P. Wardman, "Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects," Free Radical Biology and Medicine, vol. 43, no. 7, pp. 995-1022, 2007.
57. M. Wrona, K. Patel, and P. Wardman, "Reactivity of 2,7dichlorodihydrofluorescein and dihydrorhodamine 123 and their oxidized forms toward carbonate, nitrogen dioxide, and hydroxyl radicals," Free Radical Biology and Medicine, vol. 38, no. 2, pp. 262-270, 2005.
58. I. Tanida, T. Ueno, and E. Kominami, "LC3 and autophagy," Methods in Molecular Biology, vol. 445, pp. 77-88, 2008.
59. N. Mizushima and T. Yoshimori, "How to interpret LC3 immunoblotting," Autophagy, vol. 3, no. 6, pp. 542-545, 2007.
60. C. Lin, S.-C. Tsai,M. T. Tseng et al., "AKT serine/threonine protein kinase modulates baicalin-triggered autophagy in human bladder cancer T24 cells," International Journal of Oncology, vol. 42, no. 3, pp. 993-1000, 2013.
61. D. M. Arduíno, A. R. Esteves, L. Cortes et al., "Mitochondrial metabolism in Parkinson's disease impairs quality control autophagy by hampering microtubule-dependent traffic," HumanMolecular Genetics, vol. 21, no. 21, pp. 4680-4702, 2012.
62. H. Bugaut, M. Bruchard, H. Berger et al., "Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cells," PLoS ONE, vol. 8, no. 6,Article ID e65181, 2013.
63. C. L. Oeste, E. Seco, W. F. Patton, P. Boya, and D. Pérez-Sala, "Interactions between autophagic and endo-lysosomalmarkers in endothelial cells," Histochemistry and Cell Biology, vol. 139, no. 5, pp. 659-670, 2013.
64. C. Zhou, Y. Huang, and S. Przedborski, "Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance," Annals of the New York Academy of Sciences, vol. 1147, pp. 93-104, 2008.
65. V. P.-D. L. Cruz, D. Elinos-Calderón, P. Carrillo-Mora et al., "Time-course correlation of early toxic events in three models of striatal damage: modulation by proteases inhibition," Neurochemistry International, vol. 56, no. 6-7, pp. 834-842, 2010.
66. B. Dehay, J. Bové, N. Rodríguez-Muela et al., "Pathogenic lysosomal depletion in Parkinson's disease," Journal of Neuroscience, vol. 30, no. 37, pp. 12535-12544, 2010.
67. R. Köchl, X. W. Hu, E. Y. Chan, and S. A. Tooze, "Microtubules facilitate autophagosome formation and fusion of autophagosomes with endosomes," Traffic, vol. 7, no. 2, pp. 129-145, 2006.
68. T. Zhang, J. Li, Y. Dong et al., "Cucurbitacin e inhibits breast tumor metastasis by suppressing cell migration and invasion," Breast Cancer Research and Treatment, vol. 135, no. 2, pp. 445-458, 2012.
69. Y.-C. Hsu,M.-J. Chen, and T.-Y. Huang, "Inducement ofmitosis delay by cucurbitacin E, a novel tetracyclic triterpene from climbing stem of Cucumis melo L., through GADD45 in human brain malignant glioma (GBM) 8401 cells," Cell Death and Disease, vol. 5, no. 2,Article ID e1087, 2014.
70. E. A. Attard, M. Scicluna-Spiteri, M. P. Brincat, and A. Cuschieri, "The effects of Cucurbitacin E on the proliferation of prostate and breast cancer cell lines, and peripheral T-lymphocytes," Maltese FourthMedical, School Conference, vol. R034, p. 145, 1999.
71. J. Qiao, L. H. Xu, J. He, D. Y. Ouyang, and X. H. He, "Cucurbitacin E exhibits anti-inflammatory effect in RAW 264. 7 cells via suppression of NF B nuclear translocation," Inflammation Research, vol. 62, no. 5, pp. 461-469, 2013.
72. F. Pietrocola, G. Mariño, D. Lissa et al., "Pro-autophagic polyphenols reduce the acetylation of cytoplasmic proteins," Cell Cycle, vol. 11, no. 20, pp. 3851-3860, 2012.
73. G. Bureau, F. Longpré, and M.-G. Martinoli, "Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation," Journal of Neuroscience Research, vol. 86, no. 2, pp. 403-410, 2008.
74. D. K. Choi, S. Koppula, and K. Suk, "Inhibitors of microglial neurotoxicity: focus on natural products,"Molecules, vol. 16, no. 2, pp. 1021-1043, 2011.
75. V. F. Cuzzola, R. Ciurleo, S. Giacoppo, S. Marino, and P. Bramanti, "Role of resveratrol and its analogues in the treatment of neurodegenerative diseases: focus on recent discoveries," CNS & Neurological Disorders-Drug Targets, vol. 10, no. 7, pp. 849-862, 2011.
76. V. Lahaie-Collins, J. Bournival, M. Plouffe, J. Carange, and M.-G. Martinoli, "Sesamin modulates tyrosine hydroxylase, superoxide dismutase, catalase, inducible NO synthase and interleukin-6 expression in dopaminergic cells under MPP+-induced oxidative stress," OxidativeMedicine and Cellular Longevity, vol. 1, no. 1, pp. 54-62, 2008.
77. N. Hamada, Y. Fujita, A. Tanaka et al., "Metabolites of sesamin, a major lignan in sesame seeds, induce neuronal differentiation in PC12 cells through activation of ERK1/2 signaling pathway," Journal of Neural Transmission, vol. 116, no. 7, pp. 841-852, 2009.
78. M. F. Blasina, L. Vaamonde, A. Morquio, C. Echeverry, F. Arredondo, and F. Dajas, "Differentiation induced by Achyrocline satureioides (Lam) infusion in PC12 cells," Phytotherapy Research, vol. 23, no. 9, pp. 1263-1269, 2009.
79. A. El Omri, J. Han, P. Yamada, K. Kawada, M. B. Abdrabbah, and H. Isoda, "Rosmarinus officinalis polyphenols activate cholinergic activities in PC12 cells through phosphorylation of ERK1/2," Journal of Ethnopharmacology, vol. 131, no. 2, pp. 451-458, 2010.
80. J. Renaud, J. Bournival, X. Zottig, and M.-G. Martinoli, "Resveratrol Protects DAergic PC12 Cells from high glucoseinduced oxidative stress and apoptosis: effect on p53 and GRP75 localization," Neurotoxicity Research, vol. 25, no. 1, pp. 110-123, 2014.
81. T. Kadota, T. Yamaai, Y. Saito et al., "Expression of dopamine transporter at the tips of growing neurites of PC12 cells," Journal ofHistochemistry and Cytochemistry, vol. 44, no. 9, pp. 989-996, 1996.
82. J. Nilsen, G. Mor, and F. Naftolin, "Raloxifene induces neurite outgrowth in estrogen receptor positive PC12 cells," Menopause, vol. 5, no. 4, pp. 211-216, 1998.
83. K. Chiasson, V. Lahaie-Collins, J. Bournival, B. Delapierre, S. Gélinas, and M.-G. Martinoli, "Oxidative stress and 17-and 17-estradiol modulate neurofilaments differently," Journal of Molecular Neuroscience, vol. 30, no. 3, pp. 297-310, 2006.
84. T. Zhang, Y. Li, K. A. Park et al., "Cucurbitacin induces autophagy through mitochondrial ROS production which counteracts to limit caspase-dependent apoptosis," Autophagy, vol. 8, no. 4, pp. 559-576, 2012.
85. M. Xilouri, O. R. Brekk, D. Kirik, and L. Stefanis, "LAMP2A as a therapeutic target in Parkinson disease," Autophagy, vol. 9, no. 12, pp. 2166-2168, 2013.
86. F. Yang, Y.-P. Yang, C.-J. Mao et al., "Role of autophagy and proteasome degradation pathways in apoptosis of PC12 cells overexpressing human synuclein," Neuroscience Letters, vol. 454, no. 3, pp. 203-208, 2009.
87. T. Pan, S. Kondo, W. Le, and J. Jankovic, "The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease," Brain, vol. 131, no. 8, pp. 1969-1978, 2008.
88. L. Gao, T. Jiang, J. Guo et al., "Inhibition of autophagy contributes to ischemic postconditioning-induced neuroprotection against focal cerebral ischemia in rats," PLoS ONE, vol. 7, no. 9, Article ID e46092, 2012.
89. F. Xu, J. Li, W. Ni, Y.-W. Shen, and X.-P. Zhang, "Peroxisome proliferator-activated receptor agonist 15d-prostaglandin J2 mediates neuronal autophagy after cerebral ischemia-reperfusion injury," PLoS ONE, vol. 8, no. 1,Article ID e55080, 2013.
90. H. Appelqvist, P. Wäster, K. Kagedal, and K. Öllinger, "The lysosome: from waste bag to potential therapeutic target," Journal of Molecular Cell Biology, vol. 5, no. 4, pp. 214-226, 2013.
91. D. Cartelli, C. Ronchi, M. G. Maggioni, S. Rodighiero, E. Giavini, and G. Cappelletti, "Microtubule dysfunction precedes transport impairment and mitochondria damage in MPP+-induced neurodegeneration," Journal of Neurochemistry, vol. 115, no. 1, pp. 247-258, 2010.
92. S. M. Cardoso, A. R. Esteves, and D. M. Arduno, "Mitochondrial metabolic control of microtubule dynamics impairs the autophagic pathway in Parkinson's disease," Neurodegenerative Diseases, vol. 10, no. 1-4, pp. 38-40, 2012.
93. J. Demers-Lamarche, M. Grondin, A. P. Nguyen, and M. Germain, "KB1-regulated adaptive mechanisms are essential for clearance of protein aggregates and neuronal survival following mitochondrial dysfunction," in Proceedings of the 5th Canadian Association for NeuroscienceMeeting, poster no. 2-C-75, Montreal, Canada, May 2014.
94. M. German and R. S. Slack, "Dining in with BCL-2: new guests at the autophagy table," Clinical Science, vol. 118, no. 3, pp. 173-181, 2010.